Area of research
Statistics and Probability · Surgery
Research interest
Research interests include Statistical Methods in Clinical Trials, Statistical Methods and Bayesian Inference, Statistical Methods and Inference, and Advanced Causal Inference Techniques.
Expedited transfer from the scene for refractory out-of-hospital cardiac arrest in Australia: a prospective, multicentre, parallel, open label, randomised clinical trial
Confidence distributions for treatment effects in clinical trials: Posteriors without priors
A Randomized Trial of Nafamostat for Covid-19
Pre‐ and on‐treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non–small cell lung cancer
Transforming Obesity Prevention for CHILDren (TOPCHILD) Collaboration: protocol for a systematic review with individual participant data meta-analysis of behavioural interventions for the prevention of early childhood obesity
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
Unpacking the behavioural components and delivery features of early childhood obesity prevention interventions in the TOPCHILD Collaboration: a systematic review and intervention coding protocol
Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data
Penalized likelihood estimation of the proportional hazards model for survival data with interval censoring
The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials
Recurrent <scp>time‐to‐event</scp> models with ordinal outcomes
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study
Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus